Diabetic Macular Edema (DME) Enrolling by Invitation Phase 4 Trials for Nepafenac (DB06802)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03918590Post Intravitreal Injection Topical NSAID vs. PatchingTreatment